Early-Morning Hormone Panel to Differentiate Non-Classic CAH from PCOS
Order an early-morning (8 AM) 17-hydroxyprogesterone (17-OHP) level as the primary screening test, along with TSH, prolactin, total testosterone, and androstenedione to differentiate non-classic CAH from PCOS. 1
Diagnostic Algorithm
Initial Screening Panel (Early Morning, Follicular Phase)
- 17-OHP (most critical test)
- TSH (exclude thyroid disease)
- Prolactin (exclude hyperprolactinemia)
- Total testosterone
- Androstenedione
The timing is crucial: draw blood between 7-8 AM to avoid false positives from the normal diurnal variation of 17-OHP 2, 1.
Interpretation of 17-OHP Levels
Baseline 17-OHP values:
- >300 nmol/L (>10,000 ng/dL): Likely classic CAH 2
- 6-300 nmol/L (200-10,000 ng/dL): Proceed to ACTH stimulation test 2
- <6 nmol/L (<200 ng/dL): NCCAH unlikely; consider PCOS 2
Important caveat: Recent evidence suggests these cutoffs were derived from radioimmunoassay (RIA). If your lab uses ELISA, the optimal cutoff is 8.2 nmol/L rather than 6 nmol/L 3.
ACTH Stimulation Test (When Needed)
Perform when baseline 17-OHP is in the equivocal range (6-300 nmol/L or 200-10,000 ng/dL) 2, 1.
Protocol:
- Administer 250 mcg cosyntropin IV
- Measure 17-OHP at 60 minutes post-injection
Post-stimulation interpretation:
- >300 nmol/L (>10,000 ng/dL): Classic CAH 2
- 31-300 nmol/L (1,000-10,000 ng/dL): Non-classic CAH 2
- <50 nmol/L (<1,666 ng/dL): Unaffected or heterozygote 2
Key Clinical Differentiators
Features Suggesting NCCAH Over PCOS:
- Markedly elevated testosterone (>2× upper limit of normal) 4, 5
- Low LH:FSH ratio (opposite of PCOS pattern) 3, 5
- Severe hirsutism with rapid progression 4, 5
- Lack of response to standard estrogen/progestin therapy 5
- Absence of insulin resistance (more common in PCOS) 6
Features Suggesting PCOS:
- LH:FSH ratio >2
- Insulin resistance/metabolic dysfunction 6
- Polycystic ovarian morphology (though present in 40% of NCCAH) 6
Common Pitfalls to Avoid
Timing error: Drawing 17-OHP later in the day increases false positives due to diurnal variation 2
Assay method confusion: Know whether your lab uses RIA or ELISA—ELISA requires a higher cutoff (8.2 vs 6 nmol/L) 3
Assuming PCOS without screening: NCCAH affects 1.5-6.8% of hyperandrogenic women depending on ethnicity 1, 6. All women with hyperandrogenism should be screened 7, 6
Missing genetic counseling opportunity: If NCCAH is confirmed, genotyping should be performed for family planning purposes 2, 8
Overlooking ethnic risk: NCCAH prevalence varies significantly by ethnicity—higher index of suspicion in Ashkenazi Jewish, Hispanic, Slavic, and Italian populations 6
Additional Considerations
Mass spectrometry advantage: If available, liquid chromatography-tandem mass spectrometry (LC-MS/MS) for steroid profiling provides superior diagnostic accuracy compared to immunoassays, particularly for androstenedione and 21-deoxycortisol 9, 10. The elevation of 21-deoxycortisol is highly specific for 21-hydroxylase deficiency 9.
When to add genetic testing: Consider CYP21A2 genotyping when the ACTH stimulation test is equivocal or cannot be completed, or for genetic counseling purposes 2, 8.